An interventional study of Hip protection orthosis in Cerebral Palsy, sponsored by Seoul National University Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 1 Year to 10 Years. Per ClinicalTrials.gov, last updated 2022-08-24.
Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Prevention
Single Blinded, Randomized-control tiral, Multicenter clinical trial
141 studies on the registry are indexed under Hip Dislocation; 34 are open to participants now.
This study's enrollment of 66 is below the median of 90 across 91 interventional studies indexed under Hip Dislocation.
Browse Hip Dislocation studies →Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Device: Hip protection orthosis
Experimental group would wear hip protection orthosis over 12 hours a day for 1 year.
Migration index
Hip AP radiography
Time frame: 6 months
Cobb's angle (')
using radiography, expressed by degree from 0' to 180'. The closer to 0', the better the value.
Time frame: 6 months
Range of motion of hip joint (')
Using goniometer, measure the hip and knee abduction and flexion angle expressed by degree from 0' to 180'. The closer to 180', the better the value.
Time frame: 6 months
Visual analog scale
measure the pain expressed by score from 0 to 10. The closer to 10, the higher the pain.
Time frame: 6 months
Likert scale (score)
measure the satisfaction about hip protection orthosis expressed by score from 0 to 5. The closer to 5, the higher the satisfaction.
Time frame: immediately after wearing orthosis
Child Health Index of Life with Disabilities (CPCHILD)
measure the quality of life expressed by score from 0 to 100. The higher the quality of life.
Time frame: 6 months
Plan to share: No
This study is completed, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Hospital